Probing 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones as multi-target directed ligands against cholinesterases, carbonic anhydrases and α-glycosidase enzymes
作者:Sadaf Hashmi、Samra Khan、Zahid Shafiq、Parham Taslimi、Muhamamd Ishaq、Nastaran Sadeghian、Halide Sedef Karaman、Naeem Akhtar、Muhamamd Islam、Asnuzilawati Asari、Habsah Mohamad、İlhami Gulçin
DOI:10.1016/j.bioorg.2020.104554
日期:2021.2
aimed to design, develop and characterize a novel series of 4-(Diethylamino)-salicylaldehyde based thiosemicarbazones (3a-p) and evaluates their biological activity against cholinesterase, carbonic anhydrases and α-glycosidase enzymes. The hCA I isoform was inhibited by these novel 4-(diethylamino)-salicylaldehyde-based thiosemicarbazones (3a-p) in low nanomolar levels, the Ki of which differed between
随着“一药一靶”方法的消退,多靶标配体 (MTDL) 已成为现代药物化学的中心思想。本研究旨在设计、开发和表征一系列新型 4-(二乙氨基)-水杨醛基缩氨基硫脲 ( 3a-p ),并评估它们对胆碱酯酶、碳酸酐酶和 α-糖苷酶的生物活性。hCA I 异构体被这些新型 4-(二乙氨基)-水杨醛基缩氨基硫脲 ( 3a-p ) 以低纳摩尔水平抑制,其 Ki 在 407.73 ± 43.71 和 1104.11 ± 80.66 nM 之间不同。针对生理上占优势的同种型 hCA II,新化合物证明了 K is 从 323.04 ± 56.88 到 991.62 ± 77.26 nM。此外,这些新型 4-(二乙氨基)-水杨醛基缩氨基硫脲 ( 3a-p ) 有效抑制 AChE,Ki 值范围为 121.74 ± 23.52 至 548.63 ± 73.74 nM。对于 BChE,获得的 Ki 值范围为 132